FDA and FTC Issue Joint Warning Letter For CBD Products and Senator Schumer Applies Pressure on FDA to Regulate CBD

FDA and FTC Issue Joint Warning Letter For CBD Products and Senator Schumer Applies Pressure on FDA to Regulate CBD

FDA and FTC Issue Joint Warning Letter For CBD Products and Senator Schumer Applies Pressure on FDA to Regulate CBD ByTonya M. Esposito&Renee B. AppelonNovember 19, 2019 POSTED INCBD/HEMP Source: https://www.blunttruthlaw.com/2019/11/fda-and-ftc-issue-joint-warning-letter-for-cbd-products-and-senator-schumer-applies-pressure-on-fda-to-regulate-cbd/?utm_source=Seyfarth+Shaw+-+The+Blunt+Truth&utm_campaign=6017f00a93-RSS_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b58220fdbe-6017f00a93-72758269 Businesses should take note of recent developments in the CBD space. Consumer protection regulatory agencies issued another joint warning to a company selling CBD products making allegedly unsubstantiated claims. And, the FDA continues to stick to its public position that it is working toward both understanding the impact of CBD on users and crafting an effective regulatory framework. Despite this activity, Congressional leaders are still nipping at the heels of the FDA. Senator Chuck Schumer called on the FDA to issue and implement its CBD regulatory framework as soon as possible, and to report back to his office on its progress to date. In the interim, businesses will be left wondering what the rules of the road are. Joint Warning Letter Issued on October 10, 2019, the FDA and FTC partnered together to issue a joint warning to Rooted Apothecary LLC (“RA”), of Naples, Florida, for illegally selling unapproved CBD products that claim to solve a variety of health issues. RA has been accused of, among other things, claiming…